Julia Petschnigg

Julia
aims to identify novel interactors of EGFR mediated signaling
responses. With funding from a EU Marie-Curie Incoming International
Fellowship she is developing novel technologies that enable the
identification of small molecule compounds targeting specifically
oncogenic EGFR variants.